Scienture Holdings, Inc. - Common Stock (NQ:SCNX)

3.785 +0.025 (+0.66%)

Delayed Quote Updated: 11:01 AM EDT, Oct 7, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Scienture Holdings, Inc. - Common Stock

< Previous 1 2 3 Next >

Keep an eye on the top gainers and losers in Monday's session. ↗

October 27, 2025

Let's have a look at what is happening on the US markets in the middle of the day on Monday. Below you can find the top gainers and losers in today's session.

Via Chartmill

12 Health Care Stocks Moving In Monday's Intraday Session ↗

October 27, 2025

Via Benzinga

Here are the top movers in Friday's session. ↗

October 24, 2025

Let's have a look at what is happening on the US markets one hour before the close of the markets on Friday. Below you can find the top gainers and losers in today's session.

Via Chartmill

12 Health Care Stocks Moving In Friday's Intraday Session ↗

October 24, 2025

Via Benzinga

Which stocks have an unusual volume on Friday? ↗

October 24, 2025

Volume analysis on 2025-10-24: stocks with an unusual volume in today's session.

Via Chartmill

What's going on in today's session ↗

October 24, 2025

Keep an eye on the top gainers and losers in Friday's session, as they reflect the most notable price movements.

Via Chartmill

Which stocks are gapping on Friday? ↗

October 24, 2025

Let's delve into the US markets on Friday and uncover the stocks that are experiencing notable gaps in today's session. Below, you'll find the gap up and gap down stocks.

Via Chartmill

Nasdaq Surges 1%; Procter & Gamble Posts Upbeat Earnings ↗

October 24, 2025

Via Benzinga

Get insights into the top gainers and losers of Friday's pre-market session. ↗

October 24, 2025

The US market is yet to commence its session on Friday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements.

Via Chartmill

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

October 24, 2025

Via Benzinga

Why Intel Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket ↗

October 24, 2025

Via Benzinga

Intel, Scienture Holdings, Ford, Deckers, And Super Micro Computer: Why These 5 Stocks Are On Investors' Radars Today ↗

October 23, 2025

Major U.S. indices closed higher on Thursday, with the Dow Jones Industrial Average up 0.3% at 46,734.61, the S&P 500 advancing nearly 0.6% to 6,738.44.

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

October 23, 2025

Via Benzinga

Crude Oil Surges 5%; American Airlines Shares Jump After Q3 Results ↗

October 23, 2025

Via Benzinga

Here are the top movers in Thursday's session. ↗

October 23, 2025

Intrigued by the market activity one hour before the close of the markets on Thursday? Uncover the key winners and losers of today's session in our insightful analysis.

Via Chartmill

Most active stocks in Thursday's session ↗

October 23, 2025

Discover the most active stocks in Thursday's session. Stay informed about the stocks that are generating the most trading volume!

Via Chartmill

Scienture Holdings Stock Is Soaring Thursday: What's Fueling The Momentum? ↗

October 23, 2025

Shares of Scienture Holdings, Inc. (NASDAQ: SCNX) are rising Thursday after the company announced the start of commercial sales for Arbli.

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

October 23, 2025

Via Benzinga

On Thursday, there are stocks with unusual volume. Let's take a look. ↗

October 23, 2025

Let's have a look at the stocks with an unusual volume in today's session.

Via Chartmill

Which stocks are moving on Thursday? ↗

October 23, 2025

Curious about what's happening in today's session? Check out the latest stock movements and price changes.

Via Chartmill

Why Is Scienture Stock Rising Today? ↗

October 23, 2025

Scienture has commenced selling Arbli, the first FDA-approved ready-to-use liquid losartan formulation.

Via Stocktwits

Topics Artificial Intelligence

Specificity (OTCQB: SPTY) Soars as New Leadership Ignites Global Ad Tech Expansion – More Stocks Inside

October 23, 2025

Via AB Newswire

These stocks are gapping in today's session ↗

October 23, 2025

The market is buzzing with gapping stocks on Thursday. Let's uncover which stocks are experiencing notable gaps during today's session.

Via Chartmill

Dow Gains 50 Points; Tesla Shares Slide After Q3 Earnings ↗

October 23, 2025

Via Benzinga

Topics Stocks

Wondering what's happening in today's pre-market session? ↗

October 23, 2025

Discover the top movers in Thursday's pre-market session and stay informed about market dynamics.

Via Chartmill

EXCLUSIVE: Scienture Launches Arbli Oral Suspension, Expanding Options For Hypertension Patients ↗

October 23, 2025

Scienture launches Arbli, the first FDA-approved liquid losartan, expanding hypertension treatment access across US healthcare institutions.

Via Benzinga

Top 3 Health Care Stocks You'll Regret Missing In October ↗

October 21, 2025

Via Benzinga

EXCLUSIVE: Scienture Secures Hypertension Drug Purchase Agreements With 2,500 Healthcare Institutions ↗

October 01, 2025

Scienture Holdings, Inc. announced GPO agreements for its new drug, Arbli, providing access to over 2,500 healthcare institutions and plans to expand further.

Via Benzinga

EXCLUSIVE: Scienture Secures PBM-Led Rebate Agreement To Position Hypertension Drug For Rapid Adoption In US Market ↗

September 16, 2025

Scienture's Arbli, the first ready-to-use liquid losartan, gains formulary access with coverage for over 100 million lives and discussions for broader access.

Via Benzinga

Let's take a look at the stocks that are in motion in today's session. ↗

August 14, 2025

Here are the top movers in Thursday's session, showcasing the stocks with significant price changes.

Via Chartmill

< Previous 1 2 3 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.